Rapid Diagnostic Kits Market for Indian Ocean Region Countries by Product (Professional, OTC), Platform (Immunoassay, Molecular), Application (Infectious Diseases, Cardiac, Urinalysis, Cholesterol), End User (Hospitals, Diagnostic Labs)?Forecast to 2029
The rapid diagnostics kits market for Indian Ocean region countries is expected to grow at a CAGR of 1.6% from 2022 to 2029 to reach $1.75 billion by 2029.

Following thorough secondary and primary research and in-depth analysis of the market scenario, the report carries out the key industry drivers, restraints, challenges, and opportunities.

The growing demand for PoC diagnostics, the high prevalence of chronic diseases coupled with the increasing geriatric population, the growing prevalence of infectious diseases, the increasing need for rapid decision-making, and the outbreak of the COVID-19 pandemic are the key factors driving growth in the market. However, variance in test results is a restraining factor for the growth of this market. Additionally, the reluctance to change the existing diagnostic practices is a major challenge for market growth.

Based on product, in 2022, the professional kits segment is expected to account for the larger share of the rapid diagnostic kits market in Indian Ocean region countries. The large market share of this segment is attributed to increasing hospitalizations, the high prevalence of chronic diseases such as cancer and cardiac conditions, the advantages of rapid diagnostic kits over laboratory tests, including low cost and low turnaround time, and their gradual increase in the use.

Based on platform, in 2022, the immunoassays segment is expected to account for the largest share of the rapid diagnostic kits market in Indian Ocean region countries. The large market share of this segment is mainly attributed to the high prevalence of chronic and infectious diseases, technological innovations, and the advantages of rapid immunoassay tests, such as cost-effectiveness and at-home testing.

Based on application, in 2022, the infectious diseases testing segment is expected to account for the largest share of the rapid diagnostic kits market for Indian Ocean region countries. The high prevalence and outbreaks of infectious diseases and the high adoption of self-testing kits for infectious diseases are primary factors supporting the large market share of this segment.

Based on end user, in 2022, the hospitals & clinics segment is expected to account for the largest share of the rapid diagnostic kits market for Indian Ocean region countries. Factors attributing to this segment’s growth include increasing hospitalizations due to various diseases, the increasing geriatric population, and increased healthcare access & expenditure.

An in-depth analysis of the geographical scenario of the rapid diagnostic kits market for Indian Ocean region countries provides detailed qualitative and quantitative insights about the major geographies (France, India, Australia, Singapore, Indonesia, Madagascar, Mauritius, R?union, Comoros, Mayotte, and Seychelles). France is expected to account for the largest share of the rapid diagnostic kits market for Indian Ocean region countries in 2022, followed by India, Australia, Indonesia, and Singapore.

Key companies operating in the rapid diagnostic kits market for Indian Ocean region countries are Abbott Laboratories (U.S.), Becton, Dickinson and Company (U.S.), Bio-Rad Laboratories, Inc. (U.S.), F. Hoffmann-La Roche Ltd (Switzerland), ACON Laboratories, Inc. (U.S.), Danaher Corporation (U.S.), Thermo Fisher Scientific Inc. (U.S.), bioM?rieux S.A. (France), Alfa Scientific Designs, Inc. (U.S.), BTNX Inc. (Canada), Meridian Bioscience, Inc. (U.S.), and Trinity Biotech plc (Ireland).

Scope of the Report
Scope of the Report
Rapid Diagnostics Kits Market for Indian Ocean Region Countries, by Product

  • Professional Kits
  • OTC Kits


Rapid Diagnostics Kits Market for Indian Ocean Region Countries, by Platform

  • Immunoassays
  • Molecular Detection
  • Other Rapid Diagnostic Platforms


(Note – Other rapid diagnostic platforms include coagulation tests, glucose monitoring systems, and other rapid diagnostic platforms)
Rapid Diagnostics Kits Market for Indian Ocean Region Countries, by Application

  • Infectious Diseases Testing
  • Pregnancy And Fertility Testing
  • Cardiac Metabolism Testing
  • Cholesterol Testing
  • Tumor/Cancer Markers Testing
  • Blood Glucose Testing
  • Urinalysis
  • Hematology Testing
  • Other Tests


(Note - Other tests include drugs of abuse, fecal occult, and coagulation tests)
Rapid Diagnostics Kits Market for Indian Ocean Region Countries, by End User

  • Hospitals & Clinics
  • Diagnostic Laboratories
  • Home Care/Self-testing
  • Other End Users


(Note - Other end users include ambulatory care centers, nursing homes, and public places (airports, hotels, and workplaces)
Rapid Diagnostics Kits Market for Indian Ocean Region Countries, by Geography

  • France
  • India
  • Australia
  • Indonesia
  • Singapore
  • Sri Lanka
  • Madagascar
  • Mauritius
  • Reunion
  • Mayotte
  • Seychelles
  • Comoros